EHC:NYE-Encompass Health Corp (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 93.05

Change

0.00 (0.00)%

Market Cap

USD 9.22B

Volume

0.60M

Analyst Target

USD 86.07
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+3.01 (+0.77%)

USD 101.08B
UHS Universal Health Services Inc

+1.20 (+0.52%)

USD 15.29B
THC Tenet Healthcare Corporation

+4.40 (+2.78%)

USD 14.70B
DVA DaVita HealthCare Partners Inc

+5.92 (+3.76%)

USD 12.58B
CHE Chemed Corp

+5.54 (+0.97%)

USD 8.57B
NHC National HealthCare Corporatio..

+1.20 (+0.97%)

USD 1.99B
AMN AMN Healthcare Services Inc

+3.46 (+7.92%)

USD 1.66B
AGL agilon health Inc

+0.22 (+6.65%)

USD 1.36B
BKD Brookdale Senior Living Inc

+0.16 (+2.46%)

USD 1.31B
CYH Community Health Systems Inc

+0.12 (+2.14%)

USD 0.79B

ETFs Containing EHC

GLRY Inspire Faithward Mid Cap.. 3.27 % 0.00 %

+0.39 (+0.00%)

USD 0.07B
SSPX Janus Henderson U.S. Sust.. 3.18 % 0.00 %

+0.24 (+0.00%)

USD 8.63M
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

N/A

USD 0.06B
JPSV Jpmorgan Active Small Cap.. 1.82 % 0.00 %

+1.20 (+0.00%)

USD 0.02B
ENG:PA BNP Paribas EASY ECPI Glo.. 1.06 % 0.00 %

+0.83 (+0.00%)

USD 0.20B
XU61:F BNP Paribas Easy SICAV - .. 1.06 % 0.00 %

-0.02 (0.00%)

USD 0.24B
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.06 % 0.00 %

N/A

N/A
JMEE JPMorgan Market Expansion.. 0.58 % 0.00 %

+1.14 (+0.00%)

USD 1.29B
OUSM 0.00 % 0.48 %

N/A

N/A
XU61:XETRA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

+0.64 (+0.00%)

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.46% 64% D 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.46% 64% D 89% A-
Trailing 12 Months  
Capital Gain 31.07% 64% D 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.07% 64% D 84% B
Trailing 5 Years  
Capital Gain 53.07% 67% D+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.07% 67% D+ 72% C
Average Annual (5 Year Horizon)  
Capital Gain 5.49% N/A N/A 58% F
Dividend Return 6.84% N/A N/A 54% F
Total Return 1.35% N/A N/A 31% F
Risk Return Profile  
Volatility (Standard Deviation) 24.02% N/A N/A 43% F
Risk Adjusted Return 28.47% N/A N/A 48% F
Market Capitalization 9.22B 79% B- 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.